Literature DB >> 11425652

Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis.

D Yamasaki1, M Enokida, T Okano, H Hagino, R Teshima.   

Abstract

We investigated the effects of ovariectomy (ovx) and estrogen replacement therapy (ERT) on bone mineral density (BMD) and arthritis severity in rats with collagen-induced arthritis (CIA). Seven-month-old female Sprague-Dawley rats were separated into a sham group (n = 8), CIA group (n = 14), ovx group (n = 10), CIA + ovx group (n = 11), and CIA + ovx + ERT group (n = 14). In these groups, ovx was performed at 7 days, and ERT (17beta-estradiol at 20 microg/kg three times per week) was initiated 8 days after sensitization. Every 2 weeks, until 8 weeks after sensitization, arthritis score and hind paw thickness were evaluated, and BMD of the trabecular and cortical bones in the metaphysis and diaphysis of the tibia were measured by peripheral quantitative computed tomography. The arthritis score was highest in the CIA + ovx group at all timepoints after sensitization. The hind paw thickness was significantly higher in the CIA + ovx group than in the CIA group at 8 weeks after sensitization (p < 0.05). Both the arthritis score and hind paw thickness were lower in the CIA + ovx + ERT group than in the CIA + ovx group. BMD in the metaphysis was significantly decreased in both the trabecular and cortical bones in the CIA + ovx group compared with those in the CIA group at 4, 6, and 8 weeks after sensitization. In the CIA + ovx group, trabecular BMD was changed by -34 +/- 11%, and cortical BMD changed by -14 +/- 7% in the metaphysis at 8 weeks compared with those at 0 week. In the CIA group, changes of BMD in the metaphysis were -7 +/- 11% in trabecular bone and 0 +/- 7% in cortical bone. These differences of trabecular and cortical bone loss in the metaphysis were significant (both p < 0.01). BMD reduction was significantly less in the CIA + ovx + ERT group than in the CIA + ovx group at 6 and 8 weeks after sensitization. Although BMD in the diaphysis was also reduced in the groups with CIA, the degree of reduction was smaller than in the metaphysis. We conclude that ovx in CIA rats could enhance the severity of arthritis and bone loss, and that ERT could suppress arthritis and bone loss.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425652     DOI: 10.1016/s8756-3282(01)00426-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats.

Authors:  R H Nielsen; C Christiansen; M Stolina; M A Karsdal
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

2.  Biochanin A attenuates zymosan-induced arthritis in mice similarly to 17-β estradiol: an alternative to hormone replacement therapy?

Authors:  Franciel Batista Felix; Jessica Maria Dantas Araújo; Elindayane Vieira de Souza; Vanessa Pinho; Enilton Aparecido Camargo; Cristiane Bani Corrêa; Renata Grespan
Journal:  Inflamm Res       Date:  2020-09-25       Impact factor: 4.575

3.  Anti-Inflammatory Effects of the Essential Oils of Ginger (Zingiber officinale Roscoe) in Experimental Rheumatoid Arthritis.

Authors:  Janet L Funk; Jennifer B Frye; Janice N Oyarzo; Jianling Chen; Huaping Zhang; Barbara N Timmermann
Journal:  PharmaNutrition       Date:  2016-06-04

4.  Reduced ulcerogenic potential and antiarthritic effect of chitosan-naproxen sodium complexes.

Authors:  Pinaki Ghosh; Kiran S Bhise; Anant R Paradkar; S L Bodhankar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2012-06-19       Impact factor: 3.246

5.  Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis.

Authors:  C Jochems; U Islander; M Erlandsson; C Engdahl; M Lagerquist; C Ohlsson; K S Nandakumar; R Holmdahl; H Carlsten
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

6.  Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis.

Authors:  C Jochems; M Lagerquist; C Håkansson; C Ohlsson; H Carlsten
Journal:  Clin Exp Immunol       Date:  2008-04-24       Impact factor: 4.330

7.  Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis.

Authors:  Ulrika Islander; Caroline Jochems; Alexandra Stubelius; Annica Andersson; Marie K Lagerquist; Claes Ohlsson; Hans Carlsten
Journal:  Arthritis Res Ther       Date:  2011-06-20       Impact factor: 5.156

8.  Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.

Authors:  Caroline Jochems; Ulrika Islander; Malin Erlandsson; Margareta Verdrengh; Claes Ohlsson; Hans Carlsten
Journal:  Arthritis Res Ther       Date:  2005-04-27       Impact factor: 5.156

9.  The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis.

Authors:  Cecilia Engdahl; Anna E Börjesson; Huamei F Forsman; Annica Andersson; Alexandra Stubelius; Andree Krust; Pierre Chambon; Ulrika Islander; Claes Ohlsson; Hans Carlsten; Marie K Lagerquist
Journal:  Arthritis Res Ther       Date:  2014-07-15       Impact factor: 5.156

10.  Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice.

Authors:  Li Bian; Elisabet Josefsson; Ing-Marie Jonsson; Margareta Verdrengh; Claes Ohlsson; Maria Bokarewa; Andrej Tarkowski; Mattias Magnusson
Journal:  Arthritis Res Ther       Date:  2009-09-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.